Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| LAVA Therapeutics NV | LVTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 2.98 | 04:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.98 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 1.131 - 6.47 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 2.98 | USD |
LAVA Therapeutics NV Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 78.34M | 26.29M | - | 6.77M | -41.97M | -1.60 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
LAVA Therapeutics NV News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical LVTX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.88 | 3.15 | 2.6391 | 2.85 | 98,137 | 0.10 | 3.47% |
| 1 Month | 4.10 | 4.21 | 2.51 | 3.16 | 239,194 | -1.12 | -27.32% |
| 3 Months | 1.73 | 6.47 | 1.58 | 3.01 | 1,180,598 | 1.25 | 72.25% |
| 6 Months | 1.41 | 6.47 | 1.131 | 2.66 | 935,565 | 1.57 | 111.35% |
| 1 Year | 1.69 | 6.47 | 1.131 | 2.61 | 639,152 | 1.29 | 76.33% |
| 3 Years | 11.91 | 16.20 | 1.131 | 3.37 | 307,644 | -8.93 | -74.98% |
| 5 Years | 11.48 | 17.20 | 1.131 | 3.56 | 304,675 | -8.50 | -74.04% |
LAVA Therapeutics NV Description
| LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform of novel bispecific antibodies designed to selectively induce gamma-delta T cell-mediated immunity against tumor cells. |
